CRDF vs TGT · rev $145.0K vs P/E 17, rev $51.98B
Cardiff Oncology Inc (CRDF) versus Target Corporation (TGT) — a side-by-side from cached financials, not a winner call.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Michael J. Fiddelke.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
CRDF currently screens at market cap $238.8M. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Not investment advice. Open the CRDF and TGT stock pages for the full models.
Not investment advice.